High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia

Documenti analoghi

• Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF3B1 mutated refractory anaemia with ring sideroblasts
  di: Conte, Simona, et al.
  Pubblicazione: (2015)
• A three-dimensional in vitro model of erythropoiesis recapitulates erythroid failure in myelodysplastic syndromes
  di: Elvarsdóttir, Edda María, et al.
  Pubblicazione: (2019)
• Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality
  di: Dimitriou, Marios, et al.
  Pubblicazione: (2016)
• Development and Validation of a Novel RNA Sequencing–Based Prognostic Score for Acute Myeloid Leukemia
  di: Wang, Mei, et al.
  Pubblicazione: (2018)
• Progression in patients with low- and intermediate-1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations
  di: Scharenberg, Christian, et al.
  Pubblicazione: (2017)